Clinical Trial

Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers

Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
The overall goal of this feasibility study is to assess the initial safety and efficacy of LUM015 in ex vivo far-red imaging of colorectal, pancreatic, and esophageal cancers (adenocarcinoma) using the LUM Imaging System.
Protocol Amendment History 13 amendments
This ClinicalTrials.gov record has been amended 13 times since 2015-10-20; most recent amendment 2026-01-15.
Status change: Not Yet Recruiting → Recruiting 2016-05-23
Trial Details
NCT Number NCT02584244
Lead Sponsor Lumicell, Inc.
Collaborators: National Cancer Institute (NCI)
Conditions Colorectal Cancer, Pancreatic Cancer, Esophageal Cancer, Gastric Cancer
Enrollment 66 participants
Start Date 2016-08-04
Primary Completion 2026-12 (estimated)
Study Completion 2027-04 (estimated)
Updated on ClinicalTrials.gov 2026-01-16